The Future of Endocrine Therapies: Personalized Organoids And Gene Editing - Is This The Real-Life or Just Fantasy? - Applications of iPSC-derived Beta Cells: An Opportunity for Personalized Medicine for Patients with Diabetes?
Jeffrey Millman, Ph.D.
Washington University School of Medical